Gene · 5598
Papers3,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,971
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The miRNA Contribution in Adipocyte Maturation. | Noncoding RNA | 2024 | 38921832 | PubTator, text mining | PubMed |
| Imidazopyridine Compounds as ERK5 Inhibitors for Treating Cancer. | ACS Med Chem Lett | 2024 | 38894904 | PubTator, text mining | PubMed |
| ERK5 Activity Prevention Improves the Antitumor Efficacy of Fluvastatin on Thymic Carcinoma. | Anticancer Res | 2024 | 38821590 | PubTator, text mining | PubMed |
| Regulation of TAK-TAB Complex Activation through Ubiquitylation. | Front Biosci (Landmark Ed) | 2024 | 38812304 | PubTator, text mining | PubMed |
| Bone and Extracellular Signal-Related Kinase 5 (ERK5). | Biomolecules | 2024 | 38785963 | PubTator, text mining | PubMed |
| Role of Mitogen-Activated Protein (MAP) Kinase Pathways in Metabolic Diseases. | Genome Integr | 2024 | 38770527 | PubTator, text mining | PubMed |
| Role of Erk5 expressed in bone marrow mesenchymal stem cells on bone homeostasis and its potential applications in cancer treatment. | Oncoscience | 2024 | 38770443 | PubTator, text mining | PubMed |
| Latent-Transforming Growth Factor β-Binding Protein 1/Transforming Growth Factor β1 Complex Drives Antitumoral Effects upon ERK5 Targeting in Melanoma. | Am J Pathol | 2024 | 38705382 | PubTator, text mining | PubMed |
| Metal-Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells. | ACS Nano | 2024 | 38699808 | PubTator, text mining | PubMed |
| ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression. | Int J Mol Sci | 2024 | 38542254 | PubTator, text mining | PubMed |
| A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer. | BioData Min | 2024 | 38378612 | PubTator, text mining | PubMed |
| HuR promotes castration-resistant prostate cancer progression by altering ERK5 activation via posttranscriptional regulation of BCAT1. | J Transl Med | 2024 | 38369471 | PubTator, text mining | PubMed |
| Meta-analysis of microarray data to determine gene indicators involved in cisplatin resistance in non-small cell lung cancer. | Cancer Rep (Hoboken) | 2024 | 38351531 | PubTator, text mining | PubMed |
| Silymarin prevents endothelial dysfunction by upregulating Erk-5 in oxidized LDL exposed endothelial cells. | Microvasc Res | 2024 | 38307406 | PubTator, text mining | PubMed |
| IBRtools: An R package for calculating integrated biomarker indexes. | Ecol Evol | 2024 | 38304267 | PubTator, text mining | PubMed |
| Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma. | J Bone Oncol | 2024 | 38288377 | PubTator, text mining | PubMed |
| Monitoring phosphorylation and acetylation of CRISPR-mediated HiBiT-tagged endogenous proteins. | Sci Rep | 2024 | 38272933 | PubTator, text mining | PubMed |
| A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance. | Acta Pharm Sin B | 2024 | 38261805 | PubTator, text mining | PubMed |
| Role of miRNA in Cardiovascular Diseases in Children-Systematic Review. | Int J Mol Sci | 2024 | 38256030 | PubTator, text mining | PubMed |
| Let-7a-5p Regulates Animal Lipid Accumulation by Targeting Srebf2 and Thbs1 Signaling. | Int J Mol Sci | 2024 | 38255968 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5598/papers?page=8